Dr John F. Prudden

Dr. John F. Prudden Wins "Linus Pauling Scientist of the Year" Award

John F. Prudden, MD, Med. Sc.D., the "father of cartilage therapy and pioneer in the research and application of bovine tracheal cartilage in the treatment of cancer, recently received the "Linus Pauling Scientist of the Year Award for 1995."

The award, presented at the Third Annual Conference for Adjuvant Nutrition in Cancer Therapy, was given "in recognition of his altruistic efforts in forwarding the knowledge base in the field of nutrition and cancer; an uncommon persistence and brilliance in overcoming obstacles to his work; and his vision of a world without cancer."

Commenting on the award, Dr. Prudden said, "I am indeed honored to have been presented the Linus Pauling Award, and thereby to be recognized as having made a contribution towards a possible solution for one of the worst plagues of modern society, and one which our advanced technology unhappily has made more expansive and more prevalent."

In 1954, while an Associate Professor of Clinical Surgery at Columbia Presbyterian Medical Center, Dr. Prudden discovered that the introduction of cartilage into a wound accelerated its rate of healing. Convinced of the importance of this discovery, Dr. Prudden put aside his research plans and began a thorough study. During the course of his initial clinical work, he observed that in one patient who suffered from breast cancer (as well as malignant ulceration of the entire chest wall), her cancer disappeared permanently on Cartriage therapy. This discovery led him to conduct therapeutic trials on other cancer patients.

The results of his clinical research were published in many journals. In December of 1985, the Journal of Biological Response Modifiers published a meticulous report summarizing the successful results of his clinical trials with bovine cartilage. In this report, Dr. Prudden wrote that of 31 patients who participated, 90% showed a partial or complete response and 35% showed a probable or possible cure. Since then, Dr. Prudden has continued to treat cancer patients with bovine cartilage with superior results. Some of his documented remissions have follow-up histories as long as 19 years. A new report on about a hundred subsequent cases is in preparation.

Dr. Prudden serves as Chairman and Scientific Director of the Foundation for Cartilage and Immunology Research, a nonprofit educational research organization whose aim is to bring the unique properties of cartilage-based preparations to bear in the treatment of cancer, autoimmune diseases and wound healing. Dr. Prudden also maintains a private practice in New York City and Westchester County and is currently treating cancer patients throughout the United States with bovine cartilage in cooperation with their personal physicians.

The Adjuvant Nutrition in Cancer Therapy convention is sponsored by the Cancer Treatment Research Foundation (CTRF) and the American College of Nutrition (ACN). It focuses on the nutritional needs of cancer patients, explores new treatments and examines newly developed analytical tools for understanding the link between nutrition and cancer. CTRF and ACN believe that nutrition -- through food, supplements and/or parenteral means -- is an important adjunct to traditional treatments such as chemotherapy and radiation. Experts estimate that up to 40% of cancer patients die from malnutrition, not from cancer.

The Linus Pauling Award of 1995 was sponsored by Sterling Health Marketing Group, of Provo, Utah, an international distributor of nutritional products.

Previous winners have included Mark Levine, MD, for his work with vitamin C (1992) and Joel Schwartz, DMD, for his research in the use of beta carotene in the treatment of oral cancer in animals (1994). Both researchers currently work at the National Institutes of Health.

Townsend Letter for Doctors & Patients.

Share this with your friends